Clinical Trials Directory

Trials / Completed

CompletedNCT05092529

Psychological Impact of COVID-19 on Intensive Care Survivors

The Psychological Impact of Surviving an Intensive Care Admission Due to Coronavirus Disease 2019 (COVID-19) on Patients in the United Kingdom

Status
Completed
Phase
Study type
Observational
Enrollment
1,620 (actual)
Sponsor
Royal Liverpool University Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Psychological distress is commonly experienced by survivors of an intensive care admission, including patients treated during previous pandemics. Whilst data emerges about the short-term impact of COVID-19 on patients and healthcare systems, the long term impact remains unclear. The purpose of this trainee-led, multi-centre longitudinal study is to assess the short- and long-term psychological impact on patients who have survived an admission to intensive care due to COVID-19, and identify possible predictors of anxiety, depression and trauma symptoms in this patient group.

Detailed description

The primary objective is to identify the proportion of patients surviving an admission to intensive care due to COVID-19 who experience anxiety, depression and/or trauma symptoms in the 6 months post discharge. Whilst the secondary objectives are to identify demographic, clinical, physical and/or psychosocial predictors of depression, anxiety and/or trauma symptoms at 3-, 6- and 12-months post discharge from ICU. And to assess the feasibility of using a self-reported online questionnaire to assess anxiety, depression and/or trauma symptoms in patients following ICU admission. An amendment was approved by the East Midlands - Derby Research Ethics Committee on 17 March 2022, to conduct three sub-studies: 1. Semi-structured interviews - to explore the experiences of critical care survivors following COVID-19 infection during their recovery phase, including perceptions about the care received and support available to them. 2. Survey of follow-up services offered to ICU survivors - to assess geographical differences in the availability and structure of follow-up services offered to patients with critical COVID-19 after hospital discharge. 3. Survey of study team members - to gain feedback from the study team members on their involvement in the study.

Conditions

Timeline

Start date
2020-11-17
Primary completion
2023-02-14
Completion
2023-11-17
First posted
2021-10-25
Last updated
2023-11-28

Locations

50 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05092529. Inclusion in this directory is not an endorsement.